On January 23, 2021, Allena Pharmaceuticals, Inc. (the Company)
adopted the Allena Pharmaceuticals, Inc. 2021 Inducement Equity Plan (the Inducement Plan), pursuant to which the Company reserved 1,600,000 shares of its common stock for issuance under the Inducement Plan to be used exclusively for
grants of awards to individuals who were not previously employees of the Company, as an inducement material to the individuals entry into employment with the Company within the meaning of Nasdaq Listing Rule 5635(c)(4). The Inducement Plan was
approved by the Board of Directors of the Company without stockholder approval pursuant to Nasdaq Listing Rule 5635(c)(4).
The foregoing description of
the terms of the Inducement Plan is not intended to be complete and is qual ified in its entirety by reference to the Inducement Plan, a copy of which is included hereto as Exhibit 10.1 and incorporated herein by reference.
Exhibit 9.01 Financial Statements and Exhibits.
Allena Pharmaceuticals, Inc. 2021 Inducement Equity Plan
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: January 28, 2021
Allena Pharmaceuticals, Inc.
/s/ Edward Wholihan
Chief Financial Officer
makes a similar move, sign up!
Other recent filings from the company include the following: